• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Qiagen N.V. (NY: QGEN )

    44.71 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Jul 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8,638
    Open 44.71
    Bid (Size) 44.51 (2)
    Ask (Size) 44.53 (4)
    Prev. Close 44.71
    Today's Range 44.71 - 44.71
    52wk Range 34.74 - 47.32
    Shares Outstanding 227,985,334
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Strategic Buy Lights Up This Biotech Stock: Time to Invest?
    Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
    Via MarketBeat
    FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
    The FDA granted accelerated approval to Bristol Myers Squibb's Krazati (adagrasib) with cetuximab for adult patients with KRASG12C-mutated advanced or metastatic colorectal cancer. 
    Via Benzinga
    Exposures Product Safety

    Performance

    YTD
    +2.43%
    +2.43%
    1 Month
    +11.14%
    +11.14%
    3 Month
    +5.62%
    +5.62%
    6 Month
    +2.69%
    +2.69%
    1 Year
    -4.51%
    -4.51%

    More News

    Read More
    Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches
    Via Benzinga
    QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?
    Via Benzinga
    US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Earnings Scheduled For February 6, 2024
    Via Benzinga
    Earnings Preview: Qiagen
    Via Benzinga
    Where Qiagen Stands With Analysts
    Via Benzinga
    Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
    Via Benzinga
    Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects
    Via Benzinga
    Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock
    Via Benzinga
    These Companies Helped The German DAX Index Hit Its All-time High
    Via Talk Markets
    Analyst Expectations for Qiagen's Future
    Via Benzinga
    Preview: Qiagen's Earnings
    Via Benzinga
    Analyst Expectations for Qiagen's Future
    Via Benzinga
    Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends
    Via Benzinga
    QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For October 30, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.